Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles

HIV-1 Vpr, a nonstructural viral protein associated with virus particles, has a positive role in the efficient transport of PIC into the nucleus of non-dividing target cells and enhances virus replication in primary T cells. Vpr is a 96 amino acid protein and the structure by NMR shows three helical domains. Vpr has been shown to exist as dimers and higher order oligomers. Considering the multifunctional nature of Vpr, the contribution of distinct helical domains to the dimer/oligomer structure of Vpr and the relevance of this feature to its functions are not clear. To address this, we have utilized molecular modeling approaches to identify putative models of oligomerization. The predicted interface residues were subjected to site-directed mutagenesis and evaluated their role in intermolecular interaction and virion incorporation. The interaction between Vpr molecules was monitored by Bimolecular Fluorescence complementation (BiFC) method. The results show that Vpr forms oligomers in live cells and residues in helical domains play critical roles in oligomerization. Interestingly, Vpr molecules defective in oligomerization also fail to incorporate into the virus particles. Based on the data, we suggest that oligomerization of Vpr is essential for virion incorporation property and may also have a role in the events associated with virus infection.

[1]  M. Nowak,et al.  HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo , 1998, Nature Medicine.

[2]  Virion-associated HIV-1 Vpr: variable amount in virus particles derived from cells upon virus infection or proviral DNA transfection. , 2001, Virology.

[3]  R. Murali,et al.  Functional Role of Residues Corresponding to Helical Domain II (Amino Acids 35 to 46) of Human Immunodeficiency Virus Type 1 Vpr , 2000, Journal of Virology.

[4]  E. Freed,et al.  Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection , 1995, Journal of virology.

[5]  S. Mahalingam,et al.  The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles. , 1995, Virology.

[6]  Narasimhan J. Venkatachari,et al.  HIV-1 mediated immune pathogenesis: spotlight on the role of viral protein R (Vpr). , 2009, Current HIV research.

[7]  S. Benichou,et al.  The Vpr protein from HIV-1: distinct roles along the viral life cycle , 2005, Retrovirology.

[8]  B. Roques,et al.  NMR structure of the HIV-1 regulatory protein Vpr in H2O/trifluoroethanol. Comparison with the Vpr N-terminal (1-51) and C-terminal (52-96) domains. , 2002, European journal of biochemistry.

[9]  V. Planelles,et al.  The role of Vpr in HIV-1 pathogenesis. , 2005, Current HIV research.

[10]  N. Ahmad,et al.  Low conservation of functional domains of HIV type 1 vif and vpr genes in infected mothers correlates with lack of vertical transmission. , 2001, AIDS research and human retroviruses.

[11]  I. Chen,et al.  Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Enhances Expression from Unintegrated HIV-1 DNA , 2003, Journal of Virology.

[12]  H. Müller-Hermelink,et al.  Importance of vpr for infection of rhesus monkeys with simian immunodeficiency virus , 1993, Journal of virology.

[13]  A. Riva,et al.  Vpr and HIV-1 disease progression: R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients , 2006, AIDS.

[14]  Sergey Lyskov,et al.  The RosettaDock server for local protein–protein docking , 2008, Nucleic Acids Res..

[15]  Stephen R. Comeau,et al.  Predicting oligomeric assemblies: N-mers a primer. , 2005, Journal of structural biology.

[16]  M. Lenardo,et al.  Vpr Cytopathicity Independent of G2/M Cell Cycle Arrest in Human Immunodeficiency Virus Type 1-Infected CD4+ T Cells , 2007, Journal of Virology.

[17]  Simon C Watkins,et al.  Corrigendum to “Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues in Vpr-mediated transactivation and virus replication” [Virology 328 (2004) 89–100] , 2005 .

[18]  R. Connor,et al.  Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. , 1995, Virology.

[19]  W. Greene,et al.  Slipping through the door: HIV entry into the nucleus. , 2002, Microbes and infection.

[20]  F. Kirchhoff,et al.  Proline 35 of Human Immunodeficiency Virus Type 1 (HIV-1) Vpr Regulates the Integrity of the N-Terminal Helix and the Incorporation of Vpr into Virus Particles and Supports the Replication of R5-Tropic HIV-1 in Human Lymphoid Tissue Ex Vivo , 2007, Journal of Virology.

[21]  Stephen R Comeau,et al.  Performance of the first protein docking server ClusPro in CAPRI rounds 3–5 , 2005, Proteins.

[22]  Simon C Watkins,et al.  Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication. , 2004, Virology.

[23]  C. Chappey,et al.  Maintenance of an Intact Human Immunodeficiency Virus Type 1 vpr Gene following Mother-to-Infant Transmission , 1998, Journal of Virology.

[24]  D. Weiner,et al.  Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr , 1997, Journal of virology.

[25]  A. Badley,et al.  Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. , 2003, The Journal of clinical investigation.

[26]  N. Saksena,et al.  Gene defects clustered at the C-terminus of the vpr gene of HIV-1 in long-term nonprogressing mother and child pair: in vivo evolution of vpr quasispecies in blood and plasma. , 1996, Virology.

[27]  Wesley I. Sundquist,et al.  Biochemical Analyses of the Interactions between Human Immunodeficiency Virus Type 1 Vpr and p6Gag , 2001, Journal of Virology.

[28]  B. Roques,et al.  The C-terminal domain of the HIV-1 regulatory protein Vpr adopts an antiparallel dimeric structure in solution via its leucine-zipper-like domain. , 2005, The Biochemical journal.

[29]  W. Paxton,et al.  Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis , 1993, Journal of virology.

[30]  O. Narayan,et al.  Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. , 1994, The Journal of biological chemistry.

[31]  S. Mahalingam,et al.  Functional analysis of HIV-1 Vpr: identification of determinants essential for subcellular localization. , 1995, Virology.

[32]  É. Cohen,et al.  Incorporation of Vpr into Human Immunodeficiency Virus Type 1 Requires a Direct Interaction with the p6 Domain of the p55 Gag Precursor* , 1999, The Journal of Biological Chemistry.

[33]  B. Roques,et al.  NMR structure of the HIV-1 regulatory protein VPR. , 2003, Journal of molecular biology.

[34]  H. Göttlinger,et al.  Isolation of Human Immunodeficiency Virus Type 1 Cores: Retention of Vpr in the Absence of p6gag , 2000, Journal of Virology.

[35]  K. Khalili,et al.  Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[36]  D. Birx,et al.  Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus , 1995, Journal of virology.

[37]  F. Boisvert,et al.  Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation , 1995, Journal of virology.

[38]  É. Cohen,et al.  Human Immunodeficiency Virus Type 1 Vpr Is a Positive Regulator of  Viral Transcription and Infectivity in Primary Human Macrophages , 1998, The Journal of experimental medicine.

[39]  U. Schubert,et al.  Human Immunodeficiency Virus Type 1 Vpr Protein Is Incorporated into the Virion in Significantly Smaller Amounts than Gag and Is Phosphorylated in Infected Cells , 2000, Journal of Virology.

[40]  Barbara Imperiali,et al.  Protein oligomerization: how and why. , 2005, Bioorganic & medicinal chemistry.

[41]  I. Chen,et al.  Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. , 1998, Science.

[42]  M. Kamata,et al.  Novel Nuclear Import of Vpr Promoted by Importin α Is Crucial for Human Immunodeficiency Virus Type 1 Replication in Macrophages , 2007, Journal of Virology.

[43]  Ling-jun Zhao,et al.  Identification of the 15FRFG domain in HIV-1 Gag p6 essential for Vpr packaging into the virion , 2004, Retrovirology.

[44]  J. Darlix,et al.  Direct Vpr-Vpr Interaction in Cells monitored by two Photon Fluorescence Correlation Spectroscopy and Fluorescence Lifetime Imaging , 2008, Retrovirology.

[45]  H. Ariga,et al.  The Role of Vpr in the Regulation of HIV-1 Gene Expression , 2006, Cell cycle.

[46]  Michael Emerman,et al.  HIV-1 accessory proteins--ensuring viral survival in a hostile environment. , 2008, Cell host & microbe.

[47]  J. Sodroski,et al.  Human immunodeficiency virus vpr product is a virion-associated regulatory protein , 1990, Journal of virology.

[48]  M. Kamata,et al.  Virion-Associated Vpr of Human Immunodeficiency Virus Type 1 Triggers Activation of Apoptotic Events and Enhances Fas-Induced Apoptosis in Human T Cells , 2009, Journal of Virology.

[49]  J. D. De Mey,et al.  HIV-1 Vpr Oligomerization but Not That of Gag Directs the Interaction between Vpr and Gag , 2009, Journal of Virology.

[50]  Sandor Vajda,et al.  ClusPro: a fully automated algorithm for protein-protein docking , 2004, Nucleic Acids Res..

[51]  Simon C Watkins,et al.  Distinct Intracellular Trafficking of Equine Infectious Anemia Virus and Human Immunodeficiency Virus Type 1 Gag during Viral Assembly and Budding Revealed by Bimolecular Fluorescence Complementation Assays , 2007, Journal of Virology.

[52]  Victoria A. Roberts,et al.  Surveying molecular interactions with DOT , 1995 .

[53]  L. T. Ten Eyck,et al.  Protein docking using continuum electrostatics and geometric fit. , 2001, Protein engineering.